Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism APOA1 replacements(Apolipoprotein A-I replacements), APOE modulators(Apolipoprotein E modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Preclinical | US | 01 Jun 2010 |